Aosikang biology completed a new round of financing of RMB 1.5 billion
On December 28, 2021, Auscon biology (Nantong) Co., Ltd. announced the completion of a new round of financing of RMB 1.5 billion. This round of financing was led by shareholders Jinshi investment and CDH Baifu, followed by a number of well-known institutions, and Yikai capital acted as the exclusive financial adviser in this transaction. Aosikang biology is a cdmo and culture medium Biotechnology enterprise in China, focusing on the business related to biopharmaceutical production and can provide services to customers "R & D - process - production - Logistics - Technical Support - after-sales" one-stop service.
This text is a result of machine translation.
Briefing May 27, 2022 06:16 PM
· Healthcare
Oriental biology: Several monkeypox detection products have obtained EU CE certification
Briefing May 27, 2022 11:56 AM
· Healthcare
Major adjustment of Bayer's structure: combining cardiovascular and diabetes to establish the cancer business department
In-depth
Financials, Healthcare
Exclusive Interview with Zhou Mi, Managing Partner of Puhua Capital
“I entered the venture capital industry in 2008. I experienced the financial crisis in 2009 and the boom of the classical venture capital model from 2011 to 2015. Having experienced many ups and downs, I believe that venture capital will tide over the tough period and usher in new opportunities.”
May 12, 2022 05:41 PM
Briefing May 25, 2022 05:07 PM
· Healthcare
The main board of HKEx is the largest digital comprehensive service platform for the pharmaceutical industry outside the hospital in China
Briefing May 24, 2022 09:50 AM
· Healthcare
Shuoxing biological innovative nano multi antibody sm3321 was approved by ind in the United States
Apr 18, 2022 06:30 PM
Apr 22, 2021 03:11 PM
Research
Healthcare, Technology, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Briefing May 24, 2022 09:45 AM
· Healthcare
Temasek's reduction of Cinda biological
Briefing May 20, 2022 10:53 AM
· Healthcare
Haizheng pharmaceutical and Junshi biology signed a contract for commissioned production of Xinguan oral drug vv116
Briefing May 17, 2022 10:54 AM
· Healthcare
Heavy bomb in the field of hypoglycemic! Lilly tirzepatide approved for listing
Healthcare
Stem-cell Firm Hemacell Completes Pre-Series A+ Funding Round
Platelets play a crucial role in the coagulation process in vivo. However, platelets used in clinical practice mainly come from free donations and are in extreme shortage. Using stem cells to produce platelets in vitro is expected to solve this unmet clinical need.
May 27, 2022 04:55 PM
Briefing May 11, 2022 03:53 PM
· Healthcare
Roche PD-L1 combined with tigit failed in the first-line treatment of stage III non-small cell lung cancer with high expression of PD-L1
Briefing May 11, 2022 02:46 PM
· Healthcare
Foreign media said Green Valley pharmaceutical Alzheimer's disease new drug phase IX phase I ® The international phase III clinical trial has been stopped
Briefing May 11, 2022 02:18 PM
· Healthcare
The new drug registration of step pharmaceutical subsidiary was terminated, and 7.6 million R & D expenses have been invested
Technology, Healthcare
Healthcare Content Provider VanMul Receives Angle Round Funding
VanMul Health, a Chinese healthcare social media content provider, has received CNY 5 million in angel round funding. The company which founded less than a year ago, is taking a different approach to healthcare content on social media, forming deep partnerships with companies such as Douyin, Tencent, Roche, and Merck & Co.
May 27, 2022 01:50 PM
Briefing May 10, 2022 09:32 PM
· Healthcare
Pfizer acquired biohaven for about US $11.6 billion to expand the product pipeline of nervous system diseases
Briefing May 10, 2022 05:23 PM
· Healthcare
Beijing will carry out data collection standardization pilot in the field of digital medicine
Briefing Apr 27, 2022 06:47 PM
· Healthcare
Medtronic's world's first self expanding pulmonary valve was first-class recalled
See more
Read next
In-depth
In-depth
In-depth
Technology
Going Beyond Flat: Kandao QooCam EGO Transcends 'Metaverse' into the Real World
May 25, 2022 02:28 AM
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.